G. L. Morgans et al. / Tetrahedron Letters 53 (2012) 2384–2387
2387
8. Procedure giving rise to compounds 5 and 6c with Grubbs’ second generation
catalyst 4. Catalyst 4 (10 mol %) was added to N-allyl-N-[2-(allylthio)phenyl]-4-
methylbenzenesulfonamide (1c) (0.096 g, 0.27 mmol) dissolved in 1,2-
dichloroethane (25 mL) under N2. The reaction was then stirred at 65–80 °C
for 24 h with further portions of the catalyst being added until complete
consumption of starting material was observed by TLC (another 40 mol % in
10 mol % portions). The reaction mixture was then filtered through a pad of
Celite and silica gel (1:1) and the solvent removed under reduced pressure. The
resulting residue was purified by flash silica gel column chromatography (5–
20% EtOAc/hexane) to afford compounds 5 (0.028 g, 30%) as white solid prisms
(mp: 120–123 °C) and 6c (0.031 g, 34%) as yellow solid cubic prisms (mp: 170–
175 °C).
128.5, 127.9, 126.7, 125.8, 49.4, 29.8, 21.6; m/z (EI): 332 (M++1, 100%), 282
(10), 177 (15); HRMS calculated for C17H18NO2S2 (M+H)+ 332.0773, found
332.0774.
10. (a) Fringuelli, R.; Milanese, L.; Schiaffella, F. Mini-Rev. Med. Chem. 2005, 5,
1061–1073; (b) Phenothiazines and 1,4-Benzothiazines Chemical and Biomedical
Aspects; Gupta, R. R., Ed.; Elsevier: Amsterdam, The Netherlands, 1988. Vol. 4;
(c) For other examples based on 6-membered benzannulated motifs from our
research, see: Pathak, R.; Naicker, P.; Thompson, W. A.; Fernandes, M. A.; de
Koning, C. B.; van Otterlo, W. A. L. Eur. J. Org. Chem. 2007, 5337–5345; (d) van
Otterlo, W. A. L.; Pathak, R.; de Koning, C. B.; Fernandes, M. A. Tetrahedron Lett.
2004, 45, 9561–9563; (e) de Koning, C. B.; van Otterlo, W. A. L.; Michael, J. P.
Tetrahedron 2003, 59, 8337–8345.
11. 4-[(4-Methylphenyl)sulfonyl]-2-(2-methyl-2-propenyl)-3,4-dihydro-2H-1,4-
benzothiazine (14). 1H NMR (300 MHz, CDCl3): d (ppm) 7.66–7.52 (1H, m),
7.41 (2H, d, J 8.1 Hz), 7.25–7.07 (2H, m), 7.04–6.95 (3H, m), 4.78 (1H, s),
4.66 (1H, s), 4.47 (1H, dd, J 14.4, 3.6 Hz), 3.24–3.11 (1H, m), 3.00–2.80 (1H,
m), 2.32 (3H, s), 2.20 (1H, dd, J 14.2, 6.5 Hz), 2.14–1.96 (1H, m), 1.58 (3H,
s); 13C NMR (75 MHz, CDCl3): d (ppm) 144.0, 140.2, 137.4, 133.9, 129.8,
128.8, 127.5, 127.1, 126.4, 126.3, 124.4, 113.8, 50.1, 42.1, 36.8, 22.0, 21.6;
m/z (EI): 360 (M++1, 50%); HRMS calculated for C19H22NO2S2 (M+H)+
360.1087, found 360.1087.
9. Allyl-4-[(4-methylphenyl)sulfonyl]-3,4-dihydro-2H-1,4-benzothiazine (5). 1H
NMR (300 MHz, CDCl3): d (ppm) 7.67–7.62 (1H, m), 7.48 (2H, d, J 8.3 Hz),
7.21 (2H, d, J 8.3 Hz), 7.14–6.95 (3H, m), 5.77–5.63 (1H, m), 5.22–5.00 (2H, m),
4.55 (1H, dd, J 14.3, 3.8 Hz,), 3.28–3.12 (1H, m), 3.06–2.98 (1H, m), 2.40 (3H, s),
2.39–2.13 (2H, m); 13C NMR (75 MHz, CDCl3): d (ppm) 143.9, 137.3, 134.1,
132.9, 129.7, 128.7, 127.2, 127.1, 126.5, 126.3, 124.5, 118.6, 49.8, 38.9, 37.9,
21.6; m/z (EI): 345 (M+, 76%), 190 (96), 148 (100), 136 (36), 109 (25), 91 (33),
65 (26), 55 (25); HRMS calculated for C18H19NO2S2 345.0857, found 345.0837.
Crystallized from EtOAc–hexane, formula: C18H19NO2S2, M = 345.46, colour of
crystal: colourless, needle, crystal size = 0.46 0.31 0.08 mm3, a = 14.0109(19) Å,
b = 13.1138(18) Å, c = 9.3095(12) Å, b = 94.714(2)° V = 1704.7(4) Å3,
12. Tori, M.; Mizutani, R. Molecules 2010, 15, 4242–4260.
13. Zhang, Y.; Wang, J. B. Coord. Chem. Rev. 2010, 254, 941–953.
14. (a) Doyle, M. P. Chem. Rev. 1986, 86, 919–939; For a short review on the
proposed mechanism of the [1,2]-carbon shift (Stevens rearrangement) see: (b)
Bhakat, S. J. J. Chem. Pharm. Res. 2011, 3, 115–121; (c) Vanecko, J. A.; Wan, H.;
West, F. G. Tetrahedron 2006, 62, 1043–1062; (d) Marko, I. E. In Comprehensive
Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon Press: Oxford, 1991;
p 913.
15. For examples of recent reviews dealing with the importance of allyl reagents in
organic synthesis, see the following representative examples: (a) Weaver, J. D.;
Recio, A., III; Grenning, A. J.; Tunge, J. A. Chem. Rev. 2011, 111, 1846–1913; (b)
Ramadhar, T. R.; Batey, R. A. Synthesis 2011, 1321–1346; (c) Pigge, F. C. Synthesis
2010, 1745–1762; (d) Lachance, H.; Hall, D. G. Org. React. 2008, 73, 1–573.
calc = 1.346 mg/m3,
l , F(000) = 728, Z = 4, monoclinic, space
= 0.321 mmꢀ1
group P2(1)/c, T = 153(2) K, 9737 reflections collected, 3337 [R(int) = 0.0311]
independent reflections, hmax 26.00° 209 refined parameters, maximum
residual electron density 0.741 and ꢀ0.499 e.Åꢀ3, R1 = 0.0525, wR2 = 0.1114.
Crystallographic data for the structure have been deposited with the
Cambridge Crystallographic Data Centre as deposition No. CCDC-819331;
6-[(4-Methylphenyl)sulfonyl]-5,6-dihydro-2H-1,6-benzothiazocine (6c). 1H
NMR (300 MHz, CDCl3): d (ppm) 7.69 (2H, d, J 8.1 Hz), 7.36–7.31 (3H, m),
7.23–7.18 (1H, m), 7.11–7.06 (1H, m), 6.74 (1H, d, J 7.8 Hz), 5.72–5.63 (1H, m),
5.48–5.40 (1H, m), 4.54–3.71 (4H, br m), 2.46 (3H, s); 13C NMR (75 MHz,
CDCl3):
d (ppm) 143.8, 138.3, 138.0, 136.2, 131.4, 129.6, 129.1, 128.9,